Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets
Circulation: Cardiovascular Interventions · 2025
DOI: 10.1161/circinterventions.125.015430 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Rishi Puri und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic, OH (R.P.). Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement, Aortic Valve, Aortic Valve Stenosis. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: There is a paucity of data regarding the longer-term durability of transcatheter heart valves. This analysis aimed to describe the 5-year clinical outcomes and valve durability for patients treated with the Portico transcatheter heart valves across 3 studies harmonized in their prospective enrollment, inclusion/exclusion criteria, centralized independent core laboratory echocardiographic analysis, and independent clinical events committee adjudication. METHODS: Patient-level data from the PORTICO IDE randomized controlled trial, the PORTICO I postmarket study, and the PORTICO continued access protocol were pooled using a random-effects meta-analysis model. All 3 studies collected follow-up data at discharge, 30 days, and annually through 5 years. Adverse events and pooled echocardiographic data were assessed using Valve Academic Research Consortium-2 definitions. Durability definitions were adapted from Valve Academic Research Consortium-3 and European Association of Percutaneous Cardiovascular Interventions/European Society of Cardiology/European Association for Cardio-Thoracic Surgery consensus guidelines. RESULTS: A total of 1464 patients with severe symptomatic aortic stenosis and high or extreme surgical risk were included. Median age was 83 years, 61.7% were women, and the median Society of Thoracic Surgeons score was 4.9%. At 5 years, all-cause mortality and stroke rates were 49.4% and 12.3%, respectively. Transvalvular gradient and effective orifice area at 5 years were 6.2 mm Hg and 1.83 cm 2 , respectively, with paravalvular leak ≥moderate severity occurring in 1.9%. The 5-year bioprosthetic valve failure rate was 2.7%, including a 0.7% valve-related death rate and a 2.0% valve reintervention rate, but no patients with severe hemodynamic structural valve deterioration. Moderate hemodynamic structural valve deterioration occurred in 0.9% of the patients at 5 years. Hemodynamic performance and transcatheter heart valve durability remained stable irrespective of annular size. CONCLUSIONS: The use of the Portico transcatheter heart valve system in patients at high or extreme surgical risk demonstrated favorable clinical outcomes and hemodynamic performance with low transvalvular gradients and greater than mild paravalvular leak. Furthermore, bioprosthetic valve failure rates were low with no incidence of severe hemodynamic structural valve deterioration at 5 years, irrespective of annular size. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02000115 and NCT01802788.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cleveland Clinic, OH (R.P.).
- Heart Center Leipzig at Leipzig University, Germany (H.T.).
- University Heart and Vascular Center Frankfurt and Bad Segeberg, Germany (S.F.).
- University Heart Center, University of Freiburg, Germany (D.W.).
- Cedars-Sinai Medical Center, Los Angeles, CA (R.M.).
- MedStar Washington Hospital Center (R.W.).
ORCID-Profile: Rishi Puri, Holger Thiele, Dirk Westermann, Ron Waksman, Francesco Maisano, Josep Rodes-Cabau, Helge Möllmann
Zitieren
APA
Puri, R., Thiele, H., Fichtlscherer, S., Westermann, D., Makkar, R., Waksman, R., Hakmi, S., Sondergaard, L., Groh, M., Montarello, J. K., Kempfert, J., Yong, G., Bedogni, F., Maisano, F., Worthley, S. G., Rodes-Cabau, J., Fontana, G. P., & Möllmann, H. (2025). Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015430
Vancouver
Puri R, Thiele H, Fichtlscherer S, Westermann D, Makkar R, Waksman R, et al. Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.125.015430
BibTeX
@article{Puri2025,
author = {Puri, Rishi and Thiele, Holger and Fichtlscherer, Stephan and Westermann, Dirk and Makkar, Raj and Waksman, Ron and Hakmi, Samer and Sondergaard, Lars and Groh, Mark and Montarello, Joseph K and Kempfert, Joerg and Yong, Gerald and Bedogni, Francesco and Maisano, Francesco and Worthley, Stephen G and Rodes-Cabau, Josep and Fontana, Gregory P and Möllmann, Helge},
title = {Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets},
journal = {Circulation: Cardiovascular Interventions},
year = {2025},
doi = {10.1161/circinterventions.125.015430}
}
EUVIMED